Opyt primeneniya shampunya klobetazola propionata pri psoriaze volosistoy chasti golovy


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Acesso é pago ou somente para assinantes

Resumo

The efficacy and safety of the use of 0.05% clobetasol propionate shampoo in patients with psoriasis of the scalp in the acute phase. The effectiveness of the therapy was evaluated in 60 adult patients on 0, 7, 14, 21, and 28th days using a dynamic calculation of mPASI, TSS indices, and the intensity of itching. The safety of therapy was assessed by the frequency of side effects. It was shown that a daily 15-minute application of clobetasol propionate shampoo for 28 days promotes regression of psoriatic rash of the scalp, decrease of lesion area, as evidenced by a statistically significant change of dermatological mPASI, TSS indices and itching. Distinct therapeutic effect and absence of side effects have contributed to the high adherence to topical therapy of patients with psoriasis of the scalp.

Texto integral

Acesso é fechado

Bibliografia

  1. Färber E.M., Nail L. Natural history and treatment of scalp psoriasis. Cutis. 1992; 49: 396-400.
  2. Van de Kerkhof P.C., Franssen M.E. Psoriasis of the scalp. Diagnosis and Management. Am. J. Clin. Dermatol. 2001; 2: 159-65.
  3. Van de Kerkhof P.C., de Hoop D., de Korte J., Kuipers M.V. Scalp psoriasis, clinical presentations and therapeutic management. Dermatology. 1998; 197: 326-34.
  4. Heydendael V.M., de Borgie C.A., Spuls P.L., Bossuyt P.M., Bos J.D., de Rie M.A. The burden of psoriasis is not determined by disease severity only. J. Investig. Dermatol. Symp. Proc. 2004; 9: 131-5.
  5. Ortonne J., Chimenti S., Luger T., Puig L., Reid F., Trueb R.M. Scalp psoriasis: European consensus on grading and treatment algorithm. J. Eur. Acad. Dermatol. Venereol. 2009; 23: 1435-44.
  6. Papp K., Berth-Jones J., Kragballe K., Wozel G., de la Brassinne M. Scalp psoriasis: a review of current topical treatments options. J. Eur. Acad. Dermatol. Venereal. 2007; 21: 1151-60.
  7. Choi J., Koo J.Y. Quality of life issues in psoriasis. J. Am. Acad. Dermatol. 2003; 49(Suppl. 2): S57-61.
  8. Федеральные клинические рекомендации по ведению больных псориазом. Под ред. А.А. Кубановой. М., 2013. 68 с.
  9. Jarrat. M, Breneman D., Gottlieb A.B., Poulin Y., Liu Y., Foley V. Clobetasol propionate shampoo 0,05%: a new option to treat patients with moderate to severe scalp psoriasis. J. Drugs. Dermatol. 2004; 3: 367-73.
  10. Poulin Y., Papp K., Bissonnette R., Guenther L., Tan J., Lynde C., Kerrouche N., Villemagne H.; CalePso Study Team. Clobetasol propionate shampoo 0.05% is efficacious and safe for long-term control of scalp psoriasis. Cutis. 2010; 85: 43-50.
  11. Puig L., Ribera M., Hernanz J.M., Belinchon I., Santos-Juanes J., Linares M., Querol I., Colome E., Caballe G. Treatment of Scalp pspriasis: Review of the evidence and Delphi consensus of the psoriasis group of the Spanish Academy of Dermatology and Venereology. Actas. Dermosifiliogr. 2010; 101(10): 827-46.
  12. Frangos J.E., Kimball A.B. Clobetasol propionate emollient formulation foam in the treatment of corticosteroidresponsive dermatoses. Expert. Opin. Pharmacother. 2008; 9: 2001-07.

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML
Baixar

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies